Organogenesis Holding (ORGO) Reports In-Line Q1 EPS; beats on guidance

Organogenesis Holding (NASDAQ: ORGO) reported Q1 EPS of ($0.02), in-line with the analyst estimate of ($0.02). Revenue for the quarter came in at $107.6 million versus the consensus estimate of $95.52 million.

GUIDANCE:

Organogenesis Holding sees FY2023 revenue of $454-466 million, versus the consensus of $454.8 million.

For earnings history and earnings-related data on Organogenesis Holding (ORGO) click here.

You May Also Be Interested In

• John Wiley & Sons, Inc. (WLY) Tops Q1 EPS by 4c ; Offers Guidance
• Intel (INTC) PT Lowered to $92 at Mizuho
• Toro Company (TTC) Tops Q3 EPS by 3c; offers guidance